Literature DB >> 8587583

Antimicrobial susceptibilities of regional pathogenic strains of Nocardia isolated from mycetomas.

E L Durán1, A van Gelderen de Komaid.   

Abstract

The activity of antimicrobial agents against clinical isolates of Nocardia was studied by determination of the Minimal Inhibitory Concentrations (MICs) and Disk Diffusion Technique, according to the National Committee for the clinical Laboratory Standards (NCCLS). The object was: (a) to determine the 'in vitro' susceptibility of the strains that cause human mycetomas; (b) to determine the presence of different patterns of sensitivity among the regional strains; (c) to evaluate the Disk Diffusion Technique using disks commercially available with the antimicrobial concentrations normally used in the microbiological practice. Comparing the MIC values obtained with the values suggested by the National Committee for Clinical Laboratory Standards for Nocardia spp. (broth microdilution MIC breakpoints), we found that local strains are susceptible to amikacin, cefotaxime, ceftriaxone and TMP-SMZ; moderately susceptible to ampicillin and resistant to ciprofloxacin and erythromycin. The results obtained by both methods showed the presence of different patterns of sensitivity among the regional strains of N. brasiliensis. This showed strains sensitive and resistant to antibiotics. The Disk Diffusion Technique, even if it is not the adequate method to study the sensitivity patterns of different strains against antimicrobial agents, permits the differentiation between strains sensitive and resistant to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587583     DOI: 10.1007/bf01102896

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

1.  Physiological and pathogenic characteristics of Nocardia brasiliensis isolated from human mycetomas.

Authors:  A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1989-02       Impact factor: 2.574

2.  Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy.

Authors:  M Goodfellow; V A Orchard
Journal:  J Gen Microbiol       Date:  1974-08

3.  Disk diffusion susceptibility testing of Nocardia species.

Authors:  R J Wallace; E J Septimus; D M Musher; R R Martin
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

4.  Trimethoprim/sulfamethoxazole-resistant Nocardia asteroides causing multiple hepatic abscesses. Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspiration.

Authors:  F R Cockerill; R S Edson; G D Roberts; J C Waldorf
Journal:  Am J Med       Date:  1984-09       Impact factor: 4.965

5.  In vitro antimicrobial susceptibilities of Nocardia species.

Authors:  N Khardori; R Shawar; R Gupta; B Rosenbaum; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Successful treatment of a pancreatic Nocardia asteroides abscess with amikacin and surgical drainage.

Authors:  B Meier; U Metzger; F Müller; W Siegenthaler; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia.

Authors:  R J Wallace; E J Septimus; T W Williams; R H Conklin; T K Satterwhite; M B Bushby; D C Hollowell
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

8.  Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy.

Authors:  R J Wallace; K Wiss; R Curvey; P H Vance; J Steadham
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.

Authors:  L Gutmann; F W Goldstein; M D Kitzis; B Hautefort; C Darmon; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

10.  In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication.

Authors:  P Boiron; F Provost
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.